首页> 外文期刊>Seminars in radiation oncology >Adaptive radiotherapy of head and neck cancer.
【24h】

Adaptive radiotherapy of head and neck cancer.

机译:头颈癌的适应性放疗。

获取原文
获取原文并翻译 | 示例
       

摘要

Intensity-modulated radiation therapy (IMRT) in head and neck (H&N) cancer has the capability to generate steep dose gradients, leading to an improved therapeutic index. IMRT plans are typically based on a pretreatment computed tomography scan that provides a snapshot of the patient's anatomy. Nevertheless, interfractional patient variations may occur because of setup error and anatomical modifications. Therefore, the accuracy of IMRT delivery for H&N cancer may be compromised during the treatment course, potentially affecting the therapeutic index. In this framework, adaptive radiotherapy is a potential solution, which consists of "the explicit inclusion of the temporal changes in anatomy during the imaging, planning, and delivery of radiotherapy." Adaptive radiotherapy has brought an additional dimension to the management of patients with H&N cancer and has the potential to counteract the effects of positioning errors and anatomical changes. This article reviews the causes and discusses potential solutions to circumvent the discrepancies between the planned dose and the actual dose received by patients treated for H&N malignancies.
机译:头颈部(H&N)癌症中的调强放射疗法(IMRT)具有产生陡峭剂量梯度的能力,从而可提高治疗指数。 IMRT计划通常基于预处理计算机断层扫描,以提供患者解剖结构的快照。但是,由于设置错误和解剖结构的改变,可能会发生患者间部的变异。因此,在治疗过程中可能会降低针对H&N癌症的IMRT递送的准确性,可能会影响治疗指数。在这种框架下,适应性放疗是一种潜在的解决方案,它包括“在放疗的成像,规划和提供过程中明确包含解剖结构的时间变化”。适应性放疗为H&N癌症患者的治疗带来了新的层面,并有可能抵消定位错误和解剖变化的影响。本文回顾了原因,并讨论了避免因H&N恶性肿瘤而接受治疗的患者所计划的剂量与实际剂量之间的差异的潜在解决方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号